View Older Stories View More Recent Stories

Mar 16, 2025 12:41PM EPIX IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIX
Mar 15, 2025 12:12PM EPIX FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIX
Mar 13, 2025 06:18PM EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Mar 11, 2025 09:00PM ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Mar 10, 2025 06:21PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Mar 9, 2025 06:16PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Mar 8, 2025 02:55PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Mar 7, 2025 02:50PM ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Mar 6, 2025 02:45PM ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Mar 4, 2025 06:08PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Mar 1, 2025 09:46AM ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 25, 2025 07:04PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 24, 2025 06:45PM ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 23, 2025 09:48AM ROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 22, 2025 09:48PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 21, 2025 07:18PM ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 20, 2025 07:13PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 19, 2025 05:41PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 18, 2025 05:41PM ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 17, 2025 05:36PM ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 16, 2025 05:40PM ROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 15, 2025 05:40PM ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 14, 2025 05:35PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 13, 2025 05:29PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 12, 2025 01:45PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 10, 2025 11:37AM ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 7, 2025 06:15PM ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 4, 2025 11:04AM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 1, 2025 01:11PM ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
May 30, 2024 08:00AM ESSA Pharma to Present at the Jefferies Global Healthcare Conference
May 14, 2024 07:00AM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
Apr 9, 2024 08:00AM ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Mar 7, 2024 08:13PM ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Feb 13, 2024 07:00AM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023
Feb 6, 2024 08:00AM ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Jan 25, 2024 10:00AM ESSA Pharma (EPIX) Presents Updated Phase 1 Masofaniten Data
Jan 25, 2024 10:00AM ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
Dec 12, 2023 07:00AM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023
Nov 21, 2023 08:00AM ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference
Nov 8, 2023 08:00AM ESSA Pharma to Present at the Jefferies London Healthcare Conference
Oct 26, 2023 05:41PM ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat
Oct 21, 2023 09:00AM ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress
Sep 18, 2023 07:00AM ESSA Pharma Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Aug 31, 2023 07:02AM ESSA Pharma Inc. (EPIX) Insiders Establish Automatic Securities Disposition Plans
Aug 31, 2023 07:00AM ESSA Pharma Insiders Establish Automatic Securities Disposition Plans
Aug 8, 2023 07:00AM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2023
Jun 6, 2023 07:02AM ESSA Pharma Inc. (EPIX) Appoints Lauren Merendino to its Board
Jun 6, 2023 07:00AM ESSA Pharma Appoints Lauren Merendino to its Board of Directors
Jun 1, 2023 07:00AM ESSA Pharma to Present at 2023 Jefferies Healthcare Conference
May 11, 2023 07:00AM ESSA Pharma to Present at JMP Securities Life Sciences Conference
View More Recent Stories View Older Stories